Introduction
Embryonic demise is an entity with an increased incidence, with more than 25% of the 21'st century female population being affected by this pathology [1] . In more than 40% of cases, the etiology of embryonic demise is the presence of chromosomal abnormalities [2] .
Ultrasonography (US) is the preferred imaging technique in the diagnosis of embryonic demise [3] . The distance between the yolk sac (YS) and the embryo (DYSE) is an ultrasonographic parameter known to be useful in assessing the viability of the first trimester pregnancy [4] . A value of this distance of less than 3 mm directly correlates with the unfavorable evolution of the pregnancy. Correlation of this distance with serum levels of angiogenic markers may provide additional information on a pregnancy prognosis [5] . This finding has potential benefits for women with a prior miscarriage, aware of the fact that an early knowledge of the viability of the pregnancy would have a lower negative emotional impact [6] .
The first stages of embryonic development take place in a low oxygen environment. This early physiological hypoxia of the gestational sac protects the developing embryo against the teratogenic effects of free oxygen radicals [7] . A stable oxygen gradient between maternal decidua and placental tissue is also an important factor in the differentiation and migration of trophoblasts, as well as in the normal development of vilitis and angiogenesis [8] .
In normal pregnancies, there is a physiological oxidative stress in placental tissue at approximately 9-10 weeks of pregnancy, a phenomenon evidenced by an increase in serum level of the soluble form of vasculoendothelial growth factor (VEGF)(sFlt-1). As judged by adult tissue criteria, the human embryo develops in a low oxygen environment. The trophoblastic cells are extremely sensitive to oxidative stress because of their extensive cell divisions and the concomitant exposure of their DNA [3] . This phenomenon results in an increase in sFlt-1 production, which in turn can lead to a blockage of trophoblastic invasion [9] .
The identification of a low serum level of sFlt-1 before the embryonic demise suggests an inappropriate vascularization in the intervillary space and is associated with metabolic changes at the level of the implantation zone [10] . These changes consist of an increase in the oxygen level, knowing that the serum level of sFlt-1 is inversely correlated with the amount of oxygen [11] . Identifying a DYSE ≤3 mm in association with a low level of sFlt-1 could lead to more appropriate and individualized management.
The purpose of this study is to evaluate the correlation between a serum biomarker (sFlt-1) and an ultrasonographic parameter (DYSE) in assessing the prognosis of pregnancy evolutivity in the first trimester.
Material and methods
This study is a prospective case-control study that comprised 170 patients in the first trimester of pregnancy without a known associated pathology, a study conducted in "Dominic Stancaˮ Obstetrics-Gynecology Clinic between 2015-2017.
Patients were divided in 2 groups -the control group with 81 first-trimester pregnancies with DYSE >4 mm and the case group with 95 pregnant patients with DYSE ≤3 mm, both groups having amenorrhea for 6-11 weeks. In terms of the number of patients included in the study of each group, homogeneous lots were made in each amenorrhea week. For 6 patients of the case group, the prediction of the studied ultrasonographic parameter to an unfavorable evolution was not confirmed by repeated examinations, being therefore excluded from the study. Finally, the control group was formed by 89 patients.
US examination was performed with a 6.5 MHz nominal frequency endovaginal probe by the same examiner with 10 years experience in ultrasonography, using a Toshiba Aplio 300 machine. The patients were placed in dorsal decubitus with hips flexed on the abdomen at a 100˚ angle, shoulder-width abducted and the calves flexed on the hips at a 45˚ angle. In order to evaluate DYSE, it was also necessary to separately evaluate the parameters included: crown-rump length (CRL) and appearance and size of YS. There were on average 2-3 serial examinations, performed at regular intervals of 3-5 days, by the same examiner, until the final diagnosis of embryonic demise. The measurements of DYSE were performed using the sagittal section and evaluating 3 different distances from the inferior pole of the embryo and YS, the smallest of the 3 distances being considered for analysis (fig 1) . Only the first ultrasound examination was used to measure the DYSE, the others were designed to detect the viability of the embryo. The patients needed a different number of examinations until confirmation of the absence of embryonic cardiac activity.
During their first visit, from each subject enrolled in the study, 20 ml of blood were collected by venipuncture into anticoagulant-free tubes for sFlt-1 dosing. In order to obtain the data we used the Human sVEGFR1/sFLT1 PicoKine TM ELISA Kit, with range of detection between 156pg/ml and 10000 pg/ml, with a sensitivity of less than 30 pg/ml.
Patients' enrolment in study was made only after obtaining informed consent. The working methodology was approved by the Ethics Committee of the University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj-Napoca.
Statistical analysis
Descriptive statistics elements were calculated, data presented using centrality, location and distribution in- Embryo identified with endovaginal sonography. The embryo is recognized as a small linear echogenic structure (E) near the edge of the yolk sac (YS). The distance between the yolk sac and the embryo is outlined by a straight line (D). In the first image (a) the embryo has cardiac activity and is situated at 6 mm distance from the yolk sac, from a 10 weeks+ 1 day pregnancy and in the second image (b) there is no cardiac activity, the embryo is situated at 2 mm distance from the yolk sac, from a 9 weeks +1day pregnancy. Note also that a part of the amnion is visible as a membrane encircling the embryo.
dicators. The Shapiro-Wilk test was used to test normal distribution. The variance was tested using the F test. In the case of the normal distribution data, the Student (t) test was used and in the case of non-uniform distribution values or ranks, the non-parametric Mann-Whitney (U) test was used for two non-paired samples. For the analysis of three or more samples the ANOVA test was used for normal distribution data or Kruskal-Wallis nonparametric test for non-uniform values or ranges. The significance threshold for the tests used was α = 0.05 (5%), 0.01 (1%) and 0.001 respectively. The Pearson correlation coefficient (r) was used to detect the correlation between two continuous quantitative variables with normal distribution. In the case of non-uniform variables, Spearman (ρ) correlation coefficient was used. Analysis of correlation coefficients was performed using Colton's rule. The method used to obtain the mathematical equation of the dependence of a continuous variable to another variable was the linear regression. The equation of a line is y = a + bx, where a, the intercept, is the value of "y" when "x" is equal to zero and b (coefficient of regression) is the number for the gradient or slope of the straight line (regression slope). R 2 , the coefficient of determination, is the proportion of the variance in the dependent variable that is predictable from the independent variable. In linear regression R 2 is the square of the correlation coefficient.
Results
No statistically significant difference between the two groups was observed regarding the gestational age (GA) (8.49±1.59 mm for control group and 8.56±1.62 case group, p>0.05) or CRL value but a statistically significant difference was obtained when DYSE values were compared (p<0.001) (table I, fig 2) . sFlt-1 levels were significantly higher in the control group (values between 1066.91 -3961.44 pg/ml) compared with the case group (values between 568.7 -990.55 pgml) (p<0.001) (fig 3) .
A DYSE ≤3 mm, considered an abnormal distance at gestational age ≥ 6 weeks of amenorrhea, correlates with 4, fig 5) .
Discussions
In this study we showed a correlation between the serum level of sFlt-1 and the unfavorable evolution of the first trimester pregnancy but also that a DYSE value of less than 3 mm correlates with a low level of sFlt-1. Although the sFlt-1 role in the first-trimester pregnancy pathology is known [12] , to our knowledge, this is the first study in the literature to demonstrate the correlation between an ultrasound parameter (DYSE) and this serum parameter.
In its early development, the embryo is located immediately adjacent to YS. Separation of the YS from the embryo is due to the development of the embryonic structure. As the embryo develops, DYSE increases, going beyond 3 mm. For embryos with CRL ≤5 mm, there should be no separation of YS [13] . However, there is a study that demonstrated that in some pregnancies with small embryos, there is an unexpected separation of the YS from the embryo [10] . We found this situation in the 6 patients excluded from the study. In most cases when the embryo reaches a CRL >5 mm, there is a clear separation of the YS. When this separation is observed, the embryo's cardiac activity should be invariably detected. The absence of this separation could be used as a marker in the diagnosis of pregnancy with potentially reserved evolutivity [14] . Filly et al argue that this ultrasonographic parameter, respectively DYSE, is valuable in anticipating an unfavorable pregnancy evolutivity, whether used alone or in combination with other abnormal features [15] .
From the point of view of ultrasonography, the pregnancy with potentially reserved evolutivity is still an insufficiently explored topic and therefore there is a great need for prospective data on prognostic factors that could be useful in establishing a high accuracy prognosis. So, transvaginal ultrasonography has become an important method of assessing the first trimester pregnancy and is helping to identify new parameters of evolutivity [16] . The ultrasonographic diagnosis of a pregnancy with potentially reserved evolutivity is based on the quantification of specific ultrasound parameters: absence of YS or increase in size over 6 mm, YS deficiency of vascularization, embryonic bradycardia, alone or corroborated with the size of the gestational sac [17] . Callen et al considers that identifying a DYSE of less than 3 mm in size, evidenced by embryos with CRL >5 mm and without cardiac activity, even at an early stage, is defining for the diagnosis of embryonic demise. In the absence of the specific ultrasonographic signs of unfavorable evolutivity, listed above, identification of a DYSE <3 mm at an early stage of pregnancy, respectively from 6 weeks of amenorrhea, could increase the accuracy of the diagnosis [15] .
The data from our study confirmed that DYSE is an ultrasonographic parameter that indicates the risk of embryonic demise early. For an early and correct diagnosis, we considered that the correlation of DYSE with sFlt-1 might be useful and could bring valuable information regarding the early development of the pregnancy [18] .
It is noteworthy that a single serum determination of sFlt-1 between 6 and 11 weeks of amenorrhea makes it possible to distinguish between a pregnancy with an unfavorable prognosis and a pregnancy with a favorable one [19] . Daponte et al had identified that an average value of sFlt-1 of 288.79 pg/ml is associated with embryonic demise and 1390.32 pg/ml is associated with viable pregnancies [9] .
This study opens new perspectives in the assessment of the first-trimester pregnancy with potential reserved evolutivity by using the complementary data offered by ultrasonography and serological markers.
Most of the previous studies that have shown the ability of serum biomarkers to anticipate embryonic demise have been performed on cohorts of patients already experiencing symptoms of spontaneous abortion (bleeding and abdominal pain) [20, 21] . However, evaluating a biomarker in this context is of limited clinical utility, knowing that at this stage, the most appropriate investigation is serial ultrasonographic examination [22] . The data from our study, unlike a previous study [23] , highlights the importance of the parameters used for early identification of an unfavorable prognosis of pregnancy, when the embryo is still viable and the patients are asymptomatic. Also, more patients could be identified at an earlier stage of pregnancy and the ultrasound methodology and minimally invasive blood testing association ensured an accurate diagnosis for the patients enrolled in the study. On the other hand, the major limitation of this study consists of the fact that the study was conducted on a small number of patients, selected from the same region. Further larger studies are required to investigate the predictive efficiency of these markers. Also, the patients enrolled in the study passed through a stressful period once an abnormal DYSE was found until the final diagnosis. The patients were randomly selected and they were not investigated for certain specific associated pathologies, for example thrombophilia or antiphospholipidic syndrome, which may sometimes influence the prognosis of pregnancy.
Conclusions
A low level of sFlt-1 associated with a distance between the embryo and yolk sac of small dimensions, respectively <3 mm, correlates with an increased rate of non-viable embryos. This correlation between an ultrasound and a serum parameter is of great value and brings important information regarding the viability of first trimester pregnancies.
